By Sheri Kasprzak
New York, July 5 - Sirna Therapeutics, Inc. said it has completed a private placement for $28 million.
The company sold 17.5 million shares at $1.60 each to institutional and venture investors.
The investors also received warrants, but the full details of those warrants could not be determined by press time Tuesday.
The offering is expected to close later this week.
Based in Boulder, Colo., Sirna is a biotechnology company focused on developing therapies using RNA interference technologies.
| Issuer: | Sirna Therapeutics, Inc.
|
| Issue: | Stock
|
| Amount: | $28 million
|
| Shares: | 17.5 million
|
| Price: | $1.60
|
| Announcement date: | July 5
|
| Stock price: | $1.67 at close July 1
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
